SlideShare a Scribd company logo
1 of 66
Download to read offline
INFECTIVE ENDOCARDITIS
an update
Dr.T.V.Rao MD
6/21/2013 Dr.T.V.Rao MD 1
Beginning of Knowledge on
Endocarditis
• Knowledge about the
origins of endocarditis
stems from the work of
Fernel in the early
1500s, and yet this
infection still presents
physicians with major
diagnostic and
management
dilemmas.
6/21/2013 Dr.T.V.Rao MD 2
Definition of Infective Endocarditis
• Infective endocarditis, a serious infection of
the endocardium of the heart, particularly the
heart valves, is associated with a high degree
of illness and death. It generally occurs in
patients with altered and abnormal heart
architecture, in combination with exposure to
bacteria through trauma and other potentially
high-risk activities involving transient
bacteraemia.
6/21/2013 Dr.T.V.Rao MD 3
Definition
Infective Endocarditis (IE): an infection of the
heart’s endocardial surface
Main Classification:
– Native Valve IE
– Prosthetic Valve IE
Additional Consideration
– Intravenous drug abuse (IVDA) IE
– Nosocomial IE
6/21/2013 Dr.T.V.Rao MD 4
Infective Endocarditis
• Febrile illness
• Persistent bacteremia
• Characteristic lesion of microbial infection of
the endothelial surface of the heart
– Variable in size
– Amorphous mass of fibrin & platelets
– Abundant organisms
– Few inflammatory cells
The vegetation
6/21/2013 Dr.T.V.Rao MD 5
Bacterial Endocarditis
Predisposing Factors
1. Dental manipulation
2. Dental disease (caries, abscess)
3. Extra cardiac infection (lung, urinary tract,
4. skin, bone, abscess)
4. Instrumentation (urinary tract, GI tract, IV
infusions)
5. Cardiac surgery
6. Injection drug use
7. None apparent
6/21/2013 Dr.T.V.Rao MD 6
Infective Endocarditis
• Acute
– Toxic presentation
– Progressive valve destruction & metastatic infection developing in
days to weeks
– Most commonly caused by S. aureus
• Sub acute
– Mild toxicity
– Presentation over weeks to months
– Rarely leads to metastatic infection
– Most commonly S. viridans or enterococcus
6/21/2013 Dr.T.V.Rao MD 7
Infective Endocarditis
• Adult population
–Rheumatic Heart Disease
• 20 – 25% of cases of IE in 1970’s & 80’s
• 7 – 18% of cases in recent reported series
• Mitral site more common in women
• Aortic site more common in men
–Congenital Heart Disease
• 10 – 20% of cases in young adults
• 8% of cases in older adults
• PDA, VSD, bicuspid aortic valve (esp. in men>60)
6/21/2013 Dr.T.V.Rao MD 8
Infective Endocarditis
• Intravenous Drug Abuse
– Risk is 2 – 5% per pt./year
– Tendency to involve right-sided valves
• Distribution in clinical series
– 46 – 78% tricuspid
– 24 – 32% mitral
– 8 – 19% aortic
– Underlying valve normal in 75 – 93%
– S. aureus predominant organism (>50%, 60-70%
of tricuspid cases)
6/21/2013 Dr.T.V.Rao MD 9
Causes of Bacteraemia
Brushing teeth
Eating/chewing
Dental work
IV lines (colonised/infected)
IV drug use
Infected site/abscess
alpha-haemolytic
streptococci from
oral flora
Staphylococcus
aureus from
skin/nose
Strep.
pneumoniae, S.aureu
s
6/21/2013 Dr.T.V.Rao MD 10
Infecting Organisms
Common bacteria
– Alpha haem streptococci (viridans – S. mitis, S. sanguis) SUBACUTE
– Enterococci (E. faecalis) SUBACUTE
– Coagulase Negative Staphylococci – PROSTHETIC VALVES, SUBACUTE
Less common bacteria
– S. aureus ACUTE
– B-Haemolytic streptococci ACUTE
– Streptococcus pneumonia
Not so common
– Fungi
– Pseudomonas / Coliforms
– HACEK group organisms
6/21/2013 Dr.T.V.Rao MD 11
Bacterial Pathogens
HACEK Group
• Haemophilus spp.
• Actinobacillus
actinomycetemcomitans
• Cardiobacterium hominis
• Eikenella corrodens
• Kingella kingae
6/21/2013 Dr.T.V.Rao MD 12
Infecting Organisms
Streptococci 60-80%
– Alpha-haemolytic Streptococci (viridans – S. mitis, S. oralis) 30-40%
(subacute)
– Enterococci (E. faecalis) 5-18% (subacute)
– Beta-haemolytic streptococci (e.g. Gp A Strep) – rare (acute)
Staphylococci 20-35%
– S. aureus 10-27% (acute)
– Coagulase negative staphylococci (Staph epidermidis) 1-3 %
(mainly prosthetic valve risk, subacute)
Fungi
– Candida – IVDU at risk (usually indolent)
– Aspergillus – rare
Gram-negative bacteria – rare
Culture-negative endocarditis HACEK, Q-fever – cases do occur, subacute
6/21/2013 Dr.T.V.Rao MD 13
Infective Endocarditis
• Prosthetic Valve Endocarditis (PVE)
– 10 – 30% of all cases in developed nations
– Cumulative incidence
• 1.4 – 3.1% at 12 months
• 3.2 – 5.7% at 5 years
– Early PVE – within 60 days
• Nosocomial (s. epi predominates)
– Late PVE – after 60 days
• Community (same organisms as NVE)
6/21/2013 Dr.T.V.Rao MD 14
Infective Endocarditis
• Pathology
– NVE infection is largely confined to leaflets
– PVE infection commonly extends beyond valve
ring into annulus/periannular tissue
• Ring abscesses
• Septal abscesses
• Fistulae
• Prosthetic dehiscence
– Invasive infection more common in aortic position
and if onset is early
6/21/2013 Dr.T.V.Rao MD 15
Pathophysiology
Turbulent blood flow within the heart - most often
(but not always) – patient has risk factors for this
Turbulent blood flow disrupts valve surface
(endocardium) to produce suitable (sticky) site for
bacterial attachment
Platelet deposition + fibrin may lead to non-bacterial
thrombus or vegetation
Bacteraemia – delivers organisms to the damaged
(sticky) endocardial surface resulting in adherence &
colonisation
Eventual invasion of valve leaflets results in infected
vegetation (sheath of fibrin & platelets, ideal
conditions for further bacterial multiplications,
protection from polymorphs)
6/21/2013 Dr.T.V.Rao MD 16
Infected vs Normal Valve
6/21/2013 Dr.T.V.Rao MD 17
Local Spread of Infection
Acute S. aureus IE with perforation of the
aortic valve and aortic valve vegetation.
Acute S. aureus IE with mitral valve ring
abscess extending into myocardium.
6/21/2013 Dr.T.V.Rao MD 18
Turbulent Blood Flow
Rheumatic fever history
Old age – calcified valves
Mitral valve prolapse with regurgitation
Prosthetic heart valves
Congenital defects / any structural defect
Cardiac surgery
Central lines
Pacemakers
Intravenous drug abuse
Varying predisposing conditions exist, but in over 50% of cases, no identified valvular lesion
can be found.
6/21/2013 Dr.T.V.Rao MD 19
Distinction between Acute and
Subacute Bacterial Endocarditis
Feature Acute Subacute
Underlying Heart
Disease
Heart may be normal RHD,CHD, etc.
Organism S. aureus, Pneumococcus
S. pyogenes,
Enterococcus
viridans
Streptococci,
Entercoccus
Therapy Prompt, vigorous and initiated
on empirical ground
Can often be delayed
until culture reports and
susceptibilities
available
6/21/2013 Dr.T.V.Rao MD 20
Bacterial Endocarditis
Clinical Features
1. Fever. Antibiotics, salicylates, steroids, severe CHF, uremia may
mask temperature elevations.
2. Murmurs
3. Petechial and cutaneous manifestations. Roth spots Conjunctival
and mucosal petechiae, splinter hemorrhages, Osler nodes and
Janway lesions.
4. Splenomegaly
5. Embolism. Septic or sterile. CNS, spleen, lung, retinal
vessels, coronary artery, large vessels.
6. Renal disease, infarction. Multiple abscesses.
Glomerulonephritis and uremia
7. CHF
8. General. Weight loss, anorexia, debilitation, loss of libido.
6/21/2013 Dr.T.V.Rao MD 21
Symptoms
Acute
– High grade fever and
chills
– SOB
– Arthralgias/ myalgias
– Abdominal pain
– Pleuritic chest pain
– Back pain
Sub acute
– Low grade fever
– Anorexia
– Weight loss
– Fatigue
– Arthralgia's/ myalgia's
– Abdominal pain
– N/V
The onset of symptoms is usually ~2 weeks or less
from the initiating bacteremia
6/21/2013 Dr.T.V.Rao MD 22
Signs
Fever
Heart murmur
Nonspecific signs – petechiae,
subungal or “splinter” hemorrhages,
clubbing, splenomegaly, neurologic
changes
More specific signs - Osler’s Nodes,
Janeway lesions, and Roth Spots
6/21/2013 Dr.T.V.Rao MD 23
Janeway Lesions
6/21/2013 Dr.T.V.Rao MD 24
Janeway Lesions
1. More specific
2. Erythematous, blanching macules
3. Nonpainful
4. Located on palms and soles
6/21/2013 Dr.T.V.Rao MD 25
Splinter Hemorrhage
6/21/2013 Dr.T.V.Rao MD 26
Splinter Hemorrhages
1. Nonspecific
2. Nonblanching
3. Linear reddish-brown lesions found under the nail bed
4. Usually do NOT extend the entire length of the nail
6/21/2013 Dr.T.V.Rao MD 27
Subconjuctival Hemorrhages
6/21/2013 Dr.T.V.Rao MD 28
Septic Retinal Embolus
6/21/2013 Dr.T.V.Rao MD 29
Roth’s Spots
6/21/2013 Dr.T.V.Rao MD 30
6/21/2013 Dr.T.V.Rao MD 31
Osler’s Nodes
1. More specific
2. Painful and erythematous nodules
3. Located on pulp of fingers and toes
4. More common in subacute IE
6/21/2013 Dr.T.V.Rao MD 32
Bacterial Endocarditis
Laboratory Features
1. Anemia
2. Most commonly elevated WBC
3. ESR elevated, ↓ C′ in patients with
glomerulonephritis
4. Microscopic hematuria
5. Bacteremia. Persistent.≥ 3, ≤ 5 blood cultures.
Aerobic and anaerobic. Different sites.
6/21/2013 Dr.T.V.Rao MD 33
Blood cultures
• Recommendation: Blood cultures remain a
cornerstone of the diagnosis of IE cases and
should be taken prior to starting treatment in
all case
• Meticulous aseptic technique is required
when taking blood cultures, to reduce the risk
of contamination with skin
commensals, which can lead to misdiagnosis.
Guidelines for best practice should be
consulted
6/21/2013 Dr.T.V.Rao MD 34
When to Collect the blood
• In patients with a chronic or sub acute
presentation, three sets of optimally
filled blood cultures should be taken
from peripheral sites with ≥6 h between
them prior to commencing antimicrobial
therapy.
• Taking blood cultures at different times is
critical to identifying a constant
bacteraemia, a hallmark of endocarditis.
6/21/2013 Dr.T.V.Rao MD 35
Timing of blood collection
• In patients with suspected IE and severe
sepsis or septic shock at the time of
presentation, two sets of optimally filled
blood cultures should be taken at
different times within 1 h prior to
commencement of empirical therapy, to
avoid undue delay in commencing
empirical antimicrobial therapy.
6/21/2013 Dr.T.V.Rao MD 36
Start with Empherical Treatment
• It is not always appropriate to withhold
antimicrobial therapy while three sets of
blood cultures are taken over a 12 h
period. This recommendation is intended
to be pragmatic, allowing time to take at
least two sets of blood cultures (the
minimum for a secure microbiological
diagnosis) prior to commencing
antimicrobial therapy.
6/21/2013 Dr.T.V.Rao MD 37
How to collect the Blood
• Sampling of
intravascular lines
should be
avoided, unless part of
paired through-line and
peripheral sampling to
diagnose concurrent
intravascular catheter-
related bloodstream
infection.
6/21/2013 Dr.T.V.Rao MD 38
Longer Incubation is not
Needed
• In the previous BSAC guideline,1 the traditional
recommendation for extended incubation and
terminal subculture was maintained to increase the
yield of fastidious and slow-growing bacteria,
although the evidence for this was tenuous in the era
of automated continuous-monitoring blood culture
systems. In the light of further data and the proven
utility of complementary non-culture-based
technologies, the case for extended incubation and
blind subculture is not justified and therefore it is not
recommended
6/21/2013 Dr.T.V.Rao MD 39
Blood Cultures
Blood Cultures
– Minimum of three blood cultures (ideally spread over 24
hrs)
– Three separate venipuncture sites ideally
– Obtain correct volume of blood for culture bottles
Positive Result
– 1 set gives 90% sensitivity, remaining 2 sets add 8%
– Multiple same cultures are important in confirming
significance, especially for less typical organisms
Negative Result
– Prior antibiotic therapy
– ‘Culture negative endocarditis’ – fastidous orgs / non-
culturable
– May support a non-endocarditis patient diagnosis
6/21/2013 Dr.T.V.Rao MD 40
Blood Cultures
Always need to get full identification
of bacteria from positive blood
cultures in suspected endocarditis
Full sensitivity testing
Need full MIC (minimum inhibitory
concentration) for Penicillin
Liaison with Lab/microbiologist in
cases where endocarditis
suspected/diagnosed
6/21/2013 Dr.T.V.Rao MD 41
Be cautious when you send
multiple samples
• Bacteraemia is
continuous in IE
rather than
intermittent, so
positive results from
only one set out of
several blood
cultures should be
regarded with
caution.
6/21/2013 Dr.T.V.Rao MD 42
Prior administration of Antibiotics give
Negative Culture Results
• Failure to culture a causative microorganism in
IE is often due to the administration of
antimicrobials prior to blood culture, but may
also be due to infection caused by fastidious
or slow-growing microorganisms. Diagnostic
methods should include serological
investigations where they are available and a
systematic approach is advised, based on the
clinical history of the patient and their
exposure to possible risk factors.
6/21/2013 Dr.T.V.Rao MD 43
Culture Negative Results may yield
..less known microbes
• Microorganisms
that should be
considered first
include Coxiella
burnetii (Q
fever) and
Bartonella spp.
6/21/2013 Dr.T.V.Rao MD 44
Additional Tests
CBC
ESR and CRP
Complement levels (C3, C4, CH50)
RF
Urinalysis
Baseline chemistries
6/21/2013 Dr.T.V.Rao MD 45
Imaging
Chest x-ray
– Look for multiple focal infiltrates and calcification
of heart valves
ECG
– Rarely diagnostic
– Look for evidence of ischemia, conduction delay,
and arrhythmias
Echocardiography
6/21/2013 Dr.T.V.Rao MD 46
Indications for Echocardiography
Transthoracic echocardiography (TTE)
–First line if suspected IE
–Native valves
Trans esophageal echocardiography (TEE)
–Prosthetic valves
–Intracardiac complications
–Inadequate TTE
–Fungal or S. aureus or bacteremia
6/21/2013 Dr.T.V.Rao MD 47
Making the Diagnosis
Pelletier and Petersdorf criteria (1977)
– Classification scheme of definite, probable, and possible IE
– Reasonably specific but lacked sensitivity
Von Reyn criteria (1981)
– Added “rejected” as a category
– Added more clinical criteria
– Improved specificity and clinical utility
Duke criteria (1994)
– Included the role of echocardiography in diagnosis
– Added IVDA as a “predisposing heart condition”
6/21/2013 Dr.T.V.Rao MD 48
Modified Duke Criteria
Definite IE
– Microorganism (via culture or histology) in a valvular
vegetation, embolized vegetation, or intracardiac abscess
– Histologic evidence of vegetation or intracardiac abscess
Possible IE
– 2 major
– 1 major and 3 minor
– 5 minor
Rejected IE
– Resolution of illness with four days or less of antibiotics
6/21/2013 Dr.T.V.Rao MD 49
Bacterial Endocarditis
Therapy and Prophylaxis
1. Prolonged; high dosages; use of bactericidal
drugs
2. Serum antibiotic levels and MBC of the
organism
3. Viridans streptococci, Enterococcus, S.
aureus, S. pneumoniae, S. pyogenes
4. Institution of therapy on empirical grounds
5. Proven negative blood cultures on Abx
6. Prophylaxis: dental extraction, GU.
6/21/2013 Dr.T.V.Rao MD 50
Treatment
Parenteral (IV) antibiotics
–High serum concentrations to penetrate
vegetation's
–Prolonged treatment to kill dormant
bacteria clustered in vegetation's
Surgery
–Intracardiac complications/paravalve
abscess
Surveillance blood cultures
6/21/2013 Dr.T.V.Rao MD 51
Treatment - Specific
Modify empiric therapy once
cultures/sensitivities known
Long duration 4-6 weeks Rx is required
Refer to Trust Guidelines / BSAC Working Party
Guidelines (2004)
Liaise with Microbiologist
Liaise with Cardiac Surgeon if needed
Monitor response to treatment
(clinical, CRP, ECHO) & look for complications
6/21/2013 Dr.T.V.Rao MD 52
Complications
Four etiologies
–Embolic
–Local spread of infection
–Metastatic spread of infection
–Formation of immune complexes –
glomerulonephritis and arthritis
6/21/2013 Dr.T.V.Rao MD 53
Embolic Complications
Occur in up to 40% of patients with IE
Predictors of embolization
–Size of vegetation
–Left-sided vegetation's
–Fungal pathogens, S. aureus, and Strep.
Bovis
Incidence decreases significantly after
initiation of effective antibiotics
6/21/2013 Dr.T.V.Rao MD 54
Embolic Complications
Stroke
Myocardial Infarction
– Fragments of valvular vegetation or vegetation-
induced stenosis of coronary ostia
Ischemic limbs
Hypoxia from pulmonary emboli
Abdominal pain (splenic or renal infarction)
6/21/2013 Dr.T.V.Rao MD 55
Metastatic Spread of Infection
Meningitis and/or encephalitis
Vertebral osteomyelitis
Metastatic abscess
–Kidneys, spleen, brain, soft
tissues
Septic arthritis
6/21/2013 Dr.T.V.Rao MD 56
Prevention – the procedure
• Dental procedures
known to produce
bleeding
• Tonsillectomy
• Surgery involving GI,
respiratory mucosa
• Esophageal dilation
• ERCP for obstruction
• Gallbladder surgery
• Cystoscopy, urethral
dilation
• Urethral catheter if
infection present
• Urinary tract
surgery, including
prostate
• I&D of infected tissue
6/21/2013 Dr.T.V.Rao MD 57
Antibiotic Therapy
• Treatment tailored to etiologic agent
–Important to note MIC/MBC
relationship for each causative
organism and the antibiotic used
–High serum concentration necessary to
penetrate avascular vegetation
–ID CONSULT EVERY TIME
6/21/2013 Dr.T.V.Rao MD 58
Antibiotic Therapy
• Effective antimicrobial treatment should
lead to defervescence within 7 – 10 days
–Persistent fever in:
• IE due to staph, pseudomonas, culture negative
• IE with micro vascular complications/major
emboli
• Intracardiac/extra cardiac septic complications
• Drug reaction
6/21/2013 Dr.T.V.Rao MD 59
Prevention
• Prophylactic regimen targeted against
likely organism
–Strep. viridans – oral, respiratory,
esophageal
–Enterococcus – genitourinary,
gastrointestinal
–S. aureus – infected skin, mucosal surfaces
6/21/2013 Dr.T.V.Rao MD 60
Prevention – the underlying lesion
• High risk lesions
– Prosthetic valves
– Prior IE
– Cyanotic congenital heart disease
– PDA
– AR, AS, MR,MS with MR
– VSD
– Coarctation
– Surgical systemic-pulmonary
shunts
• Intermediate risk
– MVP with murmur
– Pure MS
– Tricuspid disease
– Pulmonary stenosis
– ASH
– Bicuspid Ao valve with no
hemodynamic significance
Lesions at highest risk
6/21/2013 Dr.T.V.Rao MD 61
Current Trends
Uncommon bacteria a concern
• Endocarditis has been documented for
approximately 450 years, the diagnostic challenges
and treatment dilemmas are as real today as they
were in the time of Fernel . Major advances have
been made in the diagnosis of endocarditis, in both
laboratory and clinical (imaging) parameters, but we
are witnessing the emergence of several newly
described causal bacterial species, such as
Tropheryma whippelii and Bartonella spp., as well as
sporadic case reports of unusual and uncommon
causal organisms, including Finegoldia sp., Gemella
spp., and Abiotrophia defective.
6/21/2013 Dr.T.V.Rao MD 62
Molecular Methods
• In addition, since diagnostic methods, mainly
16S rDNA polymerase chain reaction (PCR) and
sequencing, are now beginning to identify such
infections, no evidence base exists to help determine
effective antimicrobial drug regimens to successfully
treat endocarditis caused by such organisms.
Furthermore, as specimens from many of these
infections are culture-negative, conventional
antibiotic susceptibility testing does not help the
cardiologist decide on the most suitable
antimicrobial drug regimens.
6/21/2013 Dr.T.V.Rao MD 63
New challenges in Endocarditis
• 1) the emergence of antimicrobial resistance in classic
infective endocarditis microflora, namely, the gram-
positive cocci; 2) the existence of antimicrobial
resistance in complex ecologic biofilms; 3) the changing
pattern of causal agents now regarded as important
pathogens of infective endocarditis, e.g., Bartonella
spp., T. whippelii, and fungi; and 4) changing
epidemiologic trends of persons who acquire infective
endocarditis, including injection drug users, persons
with HIV/AIDS, children with congenital heart
defects, and persons undergoing body piercing.
6/21/2013 Dr.T.V.Rao MD 64
References
• Emerging Issues in Infective Endocarditis
Beverley C. Millar* and John E. Moore
• Guidelines for the diagnosis and
antibiotic treatment of endocarditis in
adults: a report of the Working Party of
the British Society for Antimicrobial
Chemotherapy F. Kate Gould etal
6/21/2013 Dr.T.V.Rao MD 65
• The Programme created by
Dr.T.V.Rao MD for Medical
Professionals in the Developing
World
• Email
• doctortvrao@gmail.com
6/21/2013 Dr.T.V.Rao MD 66

More Related Content

What's hot

Eisenmenger syndrome
Eisenmenger syndromeEisenmenger syndrome
Eisenmenger syndrome
Fuad Farooq
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
Amith Kumar
 
Rheumatic heart disease
Rheumatic heart diseaseRheumatic heart disease
Rheumatic heart disease
adolescent4u
 

What's hot (20)

Eisenmenger syndrome
Eisenmenger syndromeEisenmenger syndrome
Eisenmenger syndrome
 
dialated cardiomyopathies
dialated cardiomyopathiesdialated cardiomyopathies
dialated cardiomyopathies
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
ATRIAL FIBRILLATION
ATRIAL FIBRILLATIONATRIAL FIBRILLATION
ATRIAL FIBRILLATION
 
Aortic Aneurysms
Aortic AneurysmsAortic Aneurysms
Aortic Aneurysms
 
Endocarditis
EndocarditisEndocarditis
Endocarditis
 
peripherial arterial disease
peripherial arterial diseaseperipherial arterial disease
peripherial arterial disease
 
Aortic stenosis
Aortic stenosis Aortic stenosis
Aortic stenosis
 
Aortic regurgitation
Aortic regurgitationAortic regurgitation
Aortic regurgitation
 
Myocarditis
MyocarditisMyocarditis
Myocarditis
 
Complications of acute mi
Complications of acute miComplications of acute mi
Complications of acute mi
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditis Infective endocarditis
Infective endocarditis
 
Rheumatic Heart disease
Rheumatic Heart diseaseRheumatic Heart disease
Rheumatic Heart disease
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis in children
Infective endocarditis in childrenInfective endocarditis in children
Infective endocarditis in children
 
Aortic stenosis
Aortic stenosisAortic stenosis
Aortic stenosis
 
Rheumatic heart disease
Rheumatic heart diseaseRheumatic heart disease
Rheumatic heart disease
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Rheumatic heart disease
Rheumatic heart diseaseRheumatic heart disease
Rheumatic heart disease
 

Similar to infectiveendocarditisnet-130621100221-phpapp01 (1).pdf

Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
pochao
 
infectiveendocarditis-july2015-190917173103.pdf
infectiveendocarditis-july2015-190917173103.pdfinfectiveendocarditis-july2015-190917173103.pdf
infectiveendocarditis-july2015-190917173103.pdf
HaroonButt17
 

Similar to infectiveendocarditisnet-130621100221-phpapp01 (1).pdf (20)

infectiveendocarditisnet-130621100221-phpapp01 (1).pptx
infectiveendocarditisnet-130621100221-phpapp01 (1).pptxinfectiveendocarditisnet-130621100221-phpapp01 (1).pptx
infectiveendocarditisnet-130621100221-phpapp01 (1).pptx
 
Infective Endocarditis- Prevention and Management
Infective Endocarditis- Prevention and ManagementInfective Endocarditis- Prevention and Management
Infective Endocarditis- Prevention and Management
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
ENDOCARDITIS - lecture.pptx
ENDOCARDITIS - lecture.pptxENDOCARDITIS - lecture.pptx
ENDOCARDITIS - lecture.pptx
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
INFECTIVE ENDOCARDITIS.pptx
INFECTIVE ENDOCARDITIS.pptxINFECTIVE ENDOCARDITIS.pptx
INFECTIVE ENDOCARDITIS.pptx
 
infective endocarditis c1.pptx Cardiovacsular system infection
infective endocarditis c1.pptx Cardiovacsular system infectioninfective endocarditis c1.pptx Cardiovacsular system infection
infective endocarditis c1.pptx Cardiovacsular system infection
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 
INFECTIVE ENDOCARDITIS.pptx
INFECTIVE ENDOCARDITIS.pptxINFECTIVE ENDOCARDITIS.pptx
INFECTIVE ENDOCARDITIS.pptx
 
infectious endocarditis.pptx
infectious endocarditis.pptxinfectious endocarditis.pptx
infectious endocarditis.pptx
 
Infective endocarditis
Infective endocarditis Infective endocarditis
Infective endocarditis
 
Infective endocarditis updated
Infective endocarditis updatedInfective endocarditis updated
Infective endocarditis updated
 
Infective endocarditis FINAL.pptx
Infective endocarditis FINAL.pptxInfective endocarditis FINAL.pptx
Infective endocarditis FINAL.pptx
 
1588923212-infective-endocarditis.ppt
1588923212-infective-endocarditis.ppt1588923212-infective-endocarditis.ppt
1588923212-infective-endocarditis.ppt
 
1588923212-infective-endocarditis.ppt
1588923212-infective-endocarditis.ppt1588923212-infective-endocarditis.ppt
1588923212-infective-endocarditis.ppt
 
Infective endocarditis 2020
Infective endocarditis 2020Infective endocarditis 2020
Infective endocarditis 2020
 
infectiveendocarditis-july2015-190917173103.pdf
infectiveendocarditis-july2015-190917173103.pdfinfectiveendocarditis-july2015-190917173103.pdf
infectiveendocarditis-july2015-190917173103.pdf
 
Infective Endocarditis
Infective EndocarditisInfective Endocarditis
Infective Endocarditis
 
Infective endocarditis
Infective endocarditisInfective endocarditis
Infective endocarditis
 

More from jiregnaetichadako

coronaryangiogram-140520060959-phpapp01.pdf
coronaryangiogram-140520060959-phpapp01.pdfcoronaryangiogram-140520060959-phpapp01.pdf
coronaryangiogram-140520060959-phpapp01.pdf
jiregnaetichadako
 
coronaryangiography-220330142539 (1).pdf
coronaryangiography-220330142539 (1).pdfcoronaryangiography-220330142539 (1).pdf
coronaryangiography-220330142539 (1).pdf
jiregnaetichadako
 
coronaryangiographymadhu-151130170912-lva1-app6892 (1).pdf
coronaryangiographymadhu-151130170912-lva1-app6892 (1).pdfcoronaryangiographymadhu-151130170912-lva1-app6892 (1).pdf
coronaryangiographymadhu-151130170912-lva1-app6892 (1).pdf
jiregnaetichadako
 
vascularaccessincardiaccatheterization-130517040431-phpapp02 (1).pdf
vascularaccessincardiaccatheterization-130517040431-phpapp02 (1).pdfvascularaccessincardiaccatheterization-130517040431-phpapp02 (1).pdf
vascularaccessincardiaccatheterization-130517040431-phpapp02 (1).pdf
jiregnaetichadako
 
heartfailurelecture-140122113443-phpapp02 (1).pdf
heartfailurelecture-140122113443-phpapp02 (1).pdfheartfailurelecture-140122113443-phpapp02 (1).pdf
heartfailurelecture-140122113443-phpapp02 (1).pdf
jiregnaetichadako
 
myocardialinfractionramesh-170504133703 (1).pdf
myocardialinfractionramesh-170504133703 (1).pdfmyocardialinfractionramesh-170504133703 (1).pdf
myocardialinfractionramesh-170504133703 (1).pdf
jiregnaetichadako
 
myocardialinfarction-150223043527-conversion-gate02 (1).pdf
myocardialinfarction-150223043527-conversion-gate02 (1).pdfmyocardialinfarction-150223043527-conversion-gate02 (1).pdf
myocardialinfarction-150223043527-conversion-gate02 (1).pdf
jiregnaetichadako
 
ecg_systemic_approach_12-lead_compressed.pdf
ecg_systemic_approach_12-lead_compressed.pdfecg_systemic_approach_12-lead_compressed.pdf
ecg_systemic_approach_12-lead_compressed.pdf
jiregnaetichadako
 
Common_Laboratory_&_Imaging_studies_in_CV_patients_k&_their_interpretation.pptx
Common_Laboratory_&_Imaging_studies_in_CV_patients_k&_their_interpretation.pptxCommon_Laboratory_&_Imaging_studies_in_CV_patients_k&_their_interpretation.pptx
Common_Laboratory_&_Imaging_studies_in_CV_patients_k&_their_interpretation.pptx
jiregnaetichadako
 

More from jiregnaetichadako (20)

DRUG_CALCULATION_PRESENTATION.pdf
DRUG_CALCULATION_PRESENTATION.pdfDRUG_CALCULATION_PRESENTATION.pdf
DRUG_CALCULATION_PRESENTATION.pdf
 
anaemia-170224190304 (1).pdf
anaemia-170224190304 (1).pdfanaemia-170224190304 (1).pdf
anaemia-170224190304 (1).pdf
 
anemia-170709121059.pdf
anemia-170709121059.pdfanemia-170709121059.pdf
anemia-170709121059.pdf
 
Regression-Logistic-4.pdf
Regression-Logistic-4.pdfRegression-Logistic-4.pdf
Regression-Logistic-4.pdf
 
DRUG_CALCULATION_PRESENTATION.pdf
DRUG_CALCULATION_PRESENTATION.pdfDRUG_CALCULATION_PRESENTATION.pdf
DRUG_CALCULATION_PRESENTATION.pdf
 
2.pdf
2.pdf2.pdf
2.pdf
 
1.ppt
1.ppt1.ppt
1.ppt
 
hypertension-200501101309 (3).pdf
hypertension-200501101309 (3).pdfhypertension-200501101309 (3).pdf
hypertension-200501101309 (3).pdf
 
Hypertension-ppt (1).pptx
Hypertension-ppt (1).pptxHypertension-ppt (1).pptx
Hypertension-ppt (1).pptx
 
coronaryangiogram-140520060959-phpapp01.pdf
coronaryangiogram-140520060959-phpapp01.pdfcoronaryangiogram-140520060959-phpapp01.pdf
coronaryangiogram-140520060959-phpapp01.pdf
 
coronaryangiography-220330142539 (1).pdf
coronaryangiography-220330142539 (1).pdfcoronaryangiography-220330142539 (1).pdf
coronaryangiography-220330142539 (1).pdf
 
coronaryangiographymadhu-151130170912-lva1-app6892 (1).pdf
coronaryangiographymadhu-151130170912-lva1-app6892 (1).pdfcoronaryangiographymadhu-151130170912-lva1-app6892 (1).pdf
coronaryangiographymadhu-151130170912-lva1-app6892 (1).pdf
 
vascularaccessincardiaccatheterization-130517040431-phpapp02 (1).pdf
vascularaccessincardiaccatheterization-130517040431-phpapp02 (1).pdfvascularaccessincardiaccatheterization-130517040431-phpapp02 (1).pdf
vascularaccessincardiaccatheterization-130517040431-phpapp02 (1).pdf
 
NUTRITION 2105-LECTURE 6B.ppt
NUTRITION 2105-LECTURE 6B.pptNUTRITION 2105-LECTURE 6B.ppt
NUTRITION 2105-LECTURE 6B.ppt
 
heartfailurelecture-140122113443-phpapp02 (1).pdf
heartfailurelecture-140122113443-phpapp02 (1).pdfheartfailurelecture-140122113443-phpapp02 (1).pdf
heartfailurelecture-140122113443-phpapp02 (1).pdf
 
lecture_5_drug_acting_on_the_heart (1).ppt
lecture_5_drug_acting_on_the_heart (1).pptlecture_5_drug_acting_on_the_heart (1).ppt
lecture_5_drug_acting_on_the_heart (1).ppt
 
myocardialinfractionramesh-170504133703 (1).pdf
myocardialinfractionramesh-170504133703 (1).pdfmyocardialinfractionramesh-170504133703 (1).pdf
myocardialinfractionramesh-170504133703 (1).pdf
 
myocardialinfarction-150223043527-conversion-gate02 (1).pdf
myocardialinfarction-150223043527-conversion-gate02 (1).pdfmyocardialinfarction-150223043527-conversion-gate02 (1).pdf
myocardialinfarction-150223043527-conversion-gate02 (1).pdf
 
ecg_systemic_approach_12-lead_compressed.pdf
ecg_systemic_approach_12-lead_compressed.pdfecg_systemic_approach_12-lead_compressed.pdf
ecg_systemic_approach_12-lead_compressed.pdf
 
Common_Laboratory_&_Imaging_studies_in_CV_patients_k&_their_interpretation.pptx
Common_Laboratory_&_Imaging_studies_in_CV_patients_k&_their_interpretation.pptxCommon_Laboratory_&_Imaging_studies_in_CV_patients_k&_their_interpretation.pptx
Common_Laboratory_&_Imaging_studies_in_CV_patients_k&_their_interpretation.pptx
 

Recently uploaded

Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
9953056974 Low Rate Call Girls In Saket, Delhi NCR
 

Recently uploaded (20)

Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7Call Girls in Gagan Vihar (delhi) call me [🔝  9953056974 🔝] escort service 24X7
Call Girls in Gagan Vihar (delhi) call me [🔝 9953056974 🔝] escort service 24X7
 
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
8980367676 Call Girls In Ahmedabad Escort Service Available 24×7 In Ahmedabad
 
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
Independent Call Girls In Jaipur { 8445551418 } ✔ ANIKA MEHTA ✔ Get High Prof...
 
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
Call Girls Vasai Virar Just Call 9630942363 Top Class Call Girl Service Avail...
 
9630942363 Genuine Call Girls In Ahmedabad Gujarat Call Girls Service
9630942363 Genuine Call Girls In Ahmedabad Gujarat Call Girls Service9630942363 Genuine Call Girls In Ahmedabad Gujarat Call Girls Service
9630942363 Genuine Call Girls In Ahmedabad Gujarat Call Girls Service
 
Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...
Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...
Saket * Call Girls in Delhi - Phone 9711199012 Escorts Service at 6k to 50k a...
 
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
(Low Rate RASHMI ) Rate Of Call Girls Jaipur ❣ 8445551418 ❣ Elite Models & Ce...
 
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
Independent Call Girls Service Mohali Sector 116 | 6367187148 | Call Girl Ser...
 
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
Call Girls in Delhi Triveni Complex Escort Service(🔝))/WhatsApp 97111⇛47426
 
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
Premium Bangalore Call Girls Jigani Dail 6378878445 Escort Service For Hot Ma...
 
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
Model Call Girls In Chennai WhatsApp Booking 7427069034 call girl service 24 ...
 
Call Girls Madurai Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Madurai Just Call 9630942363 Top Class Call Girl Service AvailableCall Girls Madurai Just Call 9630942363 Top Class Call Girl Service Available
Call Girls Madurai Just Call 9630942363 Top Class Call Girl Service Available
 
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
Andheri East ) Call Girls in Mumbai Phone No 9004268417 Elite Escort Service ...
 
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
Models Call Girls In Hyderabad 9630942363 Hyderabad Call Girl & Hyderabad Esc...
 
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
Night 7k to 12k Chennai City Center Call Girls 👉👉 7427069034⭐⭐ 100% Genuine E...
 
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
Coimbatore Call Girls in Coimbatore 7427069034 genuine Escort Service Girl 10...
 
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
Manyata Tech Park ( Call Girls ) Bangalore ✔ 6297143586 ✔ Hot Model With Sexy...
 
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
Mumbai ] (Call Girls) in Mumbai 10k @ I'm VIP Independent Escorts Girls 98333...
 
Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
Call Girls Kolkata Kalikapur 💯Call Us 🔝 8005736733 🔝 💃 Top Class Call Girl Se...
 
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
Call Girls Service Jaipur {9521753030 } ❤️VVIP BHAWNA Call Girl in Jaipur Raj...
 

infectiveendocarditisnet-130621100221-phpapp01 (1).pdf

  • 1. INFECTIVE ENDOCARDITIS an update Dr.T.V.Rao MD 6/21/2013 Dr.T.V.Rao MD 1
  • 2. Beginning of Knowledge on Endocarditis • Knowledge about the origins of endocarditis stems from the work of Fernel in the early 1500s, and yet this infection still presents physicians with major diagnostic and management dilemmas. 6/21/2013 Dr.T.V.Rao MD 2
  • 3. Definition of Infective Endocarditis • Infective endocarditis, a serious infection of the endocardium of the heart, particularly the heart valves, is associated with a high degree of illness and death. It generally occurs in patients with altered and abnormal heart architecture, in combination with exposure to bacteria through trauma and other potentially high-risk activities involving transient bacteraemia. 6/21/2013 Dr.T.V.Rao MD 3
  • 4. Definition Infective Endocarditis (IE): an infection of the heart’s endocardial surface Main Classification: – Native Valve IE – Prosthetic Valve IE Additional Consideration – Intravenous drug abuse (IVDA) IE – Nosocomial IE 6/21/2013 Dr.T.V.Rao MD 4
  • 5. Infective Endocarditis • Febrile illness • Persistent bacteremia • Characteristic lesion of microbial infection of the endothelial surface of the heart – Variable in size – Amorphous mass of fibrin & platelets – Abundant organisms – Few inflammatory cells The vegetation 6/21/2013 Dr.T.V.Rao MD 5
  • 6. Bacterial Endocarditis Predisposing Factors 1. Dental manipulation 2. Dental disease (caries, abscess) 3. Extra cardiac infection (lung, urinary tract, 4. skin, bone, abscess) 4. Instrumentation (urinary tract, GI tract, IV infusions) 5. Cardiac surgery 6. Injection drug use 7. None apparent 6/21/2013 Dr.T.V.Rao MD 6
  • 7. Infective Endocarditis • Acute – Toxic presentation – Progressive valve destruction & metastatic infection developing in days to weeks – Most commonly caused by S. aureus • Sub acute – Mild toxicity – Presentation over weeks to months – Rarely leads to metastatic infection – Most commonly S. viridans or enterococcus 6/21/2013 Dr.T.V.Rao MD 7
  • 8. Infective Endocarditis • Adult population –Rheumatic Heart Disease • 20 – 25% of cases of IE in 1970’s & 80’s • 7 – 18% of cases in recent reported series • Mitral site more common in women • Aortic site more common in men –Congenital Heart Disease • 10 – 20% of cases in young adults • 8% of cases in older adults • PDA, VSD, bicuspid aortic valve (esp. in men>60) 6/21/2013 Dr.T.V.Rao MD 8
  • 9. Infective Endocarditis • Intravenous Drug Abuse – Risk is 2 – 5% per pt./year – Tendency to involve right-sided valves • Distribution in clinical series – 46 – 78% tricuspid – 24 – 32% mitral – 8 – 19% aortic – Underlying valve normal in 75 – 93% – S. aureus predominant organism (>50%, 60-70% of tricuspid cases) 6/21/2013 Dr.T.V.Rao MD 9
  • 10. Causes of Bacteraemia Brushing teeth Eating/chewing Dental work IV lines (colonised/infected) IV drug use Infected site/abscess alpha-haemolytic streptococci from oral flora Staphylococcus aureus from skin/nose Strep. pneumoniae, S.aureu s 6/21/2013 Dr.T.V.Rao MD 10
  • 11. Infecting Organisms Common bacteria – Alpha haem streptococci (viridans – S. mitis, S. sanguis) SUBACUTE – Enterococci (E. faecalis) SUBACUTE – Coagulase Negative Staphylococci – PROSTHETIC VALVES, SUBACUTE Less common bacteria – S. aureus ACUTE – B-Haemolytic streptococci ACUTE – Streptococcus pneumonia Not so common – Fungi – Pseudomonas / Coliforms – HACEK group organisms 6/21/2013 Dr.T.V.Rao MD 11
  • 12. Bacterial Pathogens HACEK Group • Haemophilus spp. • Actinobacillus actinomycetemcomitans • Cardiobacterium hominis • Eikenella corrodens • Kingella kingae 6/21/2013 Dr.T.V.Rao MD 12
  • 13. Infecting Organisms Streptococci 60-80% – Alpha-haemolytic Streptococci (viridans – S. mitis, S. oralis) 30-40% (subacute) – Enterococci (E. faecalis) 5-18% (subacute) – Beta-haemolytic streptococci (e.g. Gp A Strep) – rare (acute) Staphylococci 20-35% – S. aureus 10-27% (acute) – Coagulase negative staphylococci (Staph epidermidis) 1-3 % (mainly prosthetic valve risk, subacute) Fungi – Candida – IVDU at risk (usually indolent) – Aspergillus – rare Gram-negative bacteria – rare Culture-negative endocarditis HACEK, Q-fever – cases do occur, subacute 6/21/2013 Dr.T.V.Rao MD 13
  • 14. Infective Endocarditis • Prosthetic Valve Endocarditis (PVE) – 10 – 30% of all cases in developed nations – Cumulative incidence • 1.4 – 3.1% at 12 months • 3.2 – 5.7% at 5 years – Early PVE – within 60 days • Nosocomial (s. epi predominates) – Late PVE – after 60 days • Community (same organisms as NVE) 6/21/2013 Dr.T.V.Rao MD 14
  • 15. Infective Endocarditis • Pathology – NVE infection is largely confined to leaflets – PVE infection commonly extends beyond valve ring into annulus/periannular tissue • Ring abscesses • Septal abscesses • Fistulae • Prosthetic dehiscence – Invasive infection more common in aortic position and if onset is early 6/21/2013 Dr.T.V.Rao MD 15
  • 16. Pathophysiology Turbulent blood flow within the heart - most often (but not always) – patient has risk factors for this Turbulent blood flow disrupts valve surface (endocardium) to produce suitable (sticky) site for bacterial attachment Platelet deposition + fibrin may lead to non-bacterial thrombus or vegetation Bacteraemia – delivers organisms to the damaged (sticky) endocardial surface resulting in adherence & colonisation Eventual invasion of valve leaflets results in infected vegetation (sheath of fibrin & platelets, ideal conditions for further bacterial multiplications, protection from polymorphs) 6/21/2013 Dr.T.V.Rao MD 16
  • 17. Infected vs Normal Valve 6/21/2013 Dr.T.V.Rao MD 17
  • 18. Local Spread of Infection Acute S. aureus IE with perforation of the aortic valve and aortic valve vegetation. Acute S. aureus IE with mitral valve ring abscess extending into myocardium. 6/21/2013 Dr.T.V.Rao MD 18
  • 19. Turbulent Blood Flow Rheumatic fever history Old age – calcified valves Mitral valve prolapse with regurgitation Prosthetic heart valves Congenital defects / any structural defect Cardiac surgery Central lines Pacemakers Intravenous drug abuse Varying predisposing conditions exist, but in over 50% of cases, no identified valvular lesion can be found. 6/21/2013 Dr.T.V.Rao MD 19
  • 20. Distinction between Acute and Subacute Bacterial Endocarditis Feature Acute Subacute Underlying Heart Disease Heart may be normal RHD,CHD, etc. Organism S. aureus, Pneumococcus S. pyogenes, Enterococcus viridans Streptococci, Entercoccus Therapy Prompt, vigorous and initiated on empirical ground Can often be delayed until culture reports and susceptibilities available 6/21/2013 Dr.T.V.Rao MD 20
  • 21. Bacterial Endocarditis Clinical Features 1. Fever. Antibiotics, salicylates, steroids, severe CHF, uremia may mask temperature elevations. 2. Murmurs 3. Petechial and cutaneous manifestations. Roth spots Conjunctival and mucosal petechiae, splinter hemorrhages, Osler nodes and Janway lesions. 4. Splenomegaly 5. Embolism. Septic or sterile. CNS, spleen, lung, retinal vessels, coronary artery, large vessels. 6. Renal disease, infarction. Multiple abscesses. Glomerulonephritis and uremia 7. CHF 8. General. Weight loss, anorexia, debilitation, loss of libido. 6/21/2013 Dr.T.V.Rao MD 21
  • 22. Symptoms Acute – High grade fever and chills – SOB – Arthralgias/ myalgias – Abdominal pain – Pleuritic chest pain – Back pain Sub acute – Low grade fever – Anorexia – Weight loss – Fatigue – Arthralgia's/ myalgia's – Abdominal pain – N/V The onset of symptoms is usually ~2 weeks or less from the initiating bacteremia 6/21/2013 Dr.T.V.Rao MD 22
  • 23. Signs Fever Heart murmur Nonspecific signs – petechiae, subungal or “splinter” hemorrhages, clubbing, splenomegaly, neurologic changes More specific signs - Osler’s Nodes, Janeway lesions, and Roth Spots 6/21/2013 Dr.T.V.Rao MD 23
  • 25. Janeway Lesions 1. More specific 2. Erythematous, blanching macules 3. Nonpainful 4. Located on palms and soles 6/21/2013 Dr.T.V.Rao MD 25
  • 27. Splinter Hemorrhages 1. Nonspecific 2. Nonblanching 3. Linear reddish-brown lesions found under the nail bed 4. Usually do NOT extend the entire length of the nail 6/21/2013 Dr.T.V.Rao MD 27
  • 32. Osler’s Nodes 1. More specific 2. Painful and erythematous nodules 3. Located on pulp of fingers and toes 4. More common in subacute IE 6/21/2013 Dr.T.V.Rao MD 32
  • 33. Bacterial Endocarditis Laboratory Features 1. Anemia 2. Most commonly elevated WBC 3. ESR elevated, ↓ C′ in patients with glomerulonephritis 4. Microscopic hematuria 5. Bacteremia. Persistent.≥ 3, ≤ 5 blood cultures. Aerobic and anaerobic. Different sites. 6/21/2013 Dr.T.V.Rao MD 33
  • 34. Blood cultures • Recommendation: Blood cultures remain a cornerstone of the diagnosis of IE cases and should be taken prior to starting treatment in all case • Meticulous aseptic technique is required when taking blood cultures, to reduce the risk of contamination with skin commensals, which can lead to misdiagnosis. Guidelines for best practice should be consulted 6/21/2013 Dr.T.V.Rao MD 34
  • 35. When to Collect the blood • In patients with a chronic or sub acute presentation, three sets of optimally filled blood cultures should be taken from peripheral sites with ≥6 h between them prior to commencing antimicrobial therapy. • Taking blood cultures at different times is critical to identifying a constant bacteraemia, a hallmark of endocarditis. 6/21/2013 Dr.T.V.Rao MD 35
  • 36. Timing of blood collection • In patients with suspected IE and severe sepsis or septic shock at the time of presentation, two sets of optimally filled blood cultures should be taken at different times within 1 h prior to commencement of empirical therapy, to avoid undue delay in commencing empirical antimicrobial therapy. 6/21/2013 Dr.T.V.Rao MD 36
  • 37. Start with Empherical Treatment • It is not always appropriate to withhold antimicrobial therapy while three sets of blood cultures are taken over a 12 h period. This recommendation is intended to be pragmatic, allowing time to take at least two sets of blood cultures (the minimum for a secure microbiological diagnosis) prior to commencing antimicrobial therapy. 6/21/2013 Dr.T.V.Rao MD 37
  • 38. How to collect the Blood • Sampling of intravascular lines should be avoided, unless part of paired through-line and peripheral sampling to diagnose concurrent intravascular catheter- related bloodstream infection. 6/21/2013 Dr.T.V.Rao MD 38
  • 39. Longer Incubation is not Needed • In the previous BSAC guideline,1 the traditional recommendation for extended incubation and terminal subculture was maintained to increase the yield of fastidious and slow-growing bacteria, although the evidence for this was tenuous in the era of automated continuous-monitoring blood culture systems. In the light of further data and the proven utility of complementary non-culture-based technologies, the case for extended incubation and blind subculture is not justified and therefore it is not recommended 6/21/2013 Dr.T.V.Rao MD 39
  • 40. Blood Cultures Blood Cultures – Minimum of three blood cultures (ideally spread over 24 hrs) – Three separate venipuncture sites ideally – Obtain correct volume of blood for culture bottles Positive Result – 1 set gives 90% sensitivity, remaining 2 sets add 8% – Multiple same cultures are important in confirming significance, especially for less typical organisms Negative Result – Prior antibiotic therapy – ‘Culture negative endocarditis’ – fastidous orgs / non- culturable – May support a non-endocarditis patient diagnosis 6/21/2013 Dr.T.V.Rao MD 40
  • 41. Blood Cultures Always need to get full identification of bacteria from positive blood cultures in suspected endocarditis Full sensitivity testing Need full MIC (minimum inhibitory concentration) for Penicillin Liaison with Lab/microbiologist in cases where endocarditis suspected/diagnosed 6/21/2013 Dr.T.V.Rao MD 41
  • 42. Be cautious when you send multiple samples • Bacteraemia is continuous in IE rather than intermittent, so positive results from only one set out of several blood cultures should be regarded with caution. 6/21/2013 Dr.T.V.Rao MD 42
  • 43. Prior administration of Antibiotics give Negative Culture Results • Failure to culture a causative microorganism in IE is often due to the administration of antimicrobials prior to blood culture, but may also be due to infection caused by fastidious or slow-growing microorganisms. Diagnostic methods should include serological investigations where they are available and a systematic approach is advised, based on the clinical history of the patient and their exposure to possible risk factors. 6/21/2013 Dr.T.V.Rao MD 43
  • 44. Culture Negative Results may yield ..less known microbes • Microorganisms that should be considered first include Coxiella burnetii (Q fever) and Bartonella spp. 6/21/2013 Dr.T.V.Rao MD 44
  • 45. Additional Tests CBC ESR and CRP Complement levels (C3, C4, CH50) RF Urinalysis Baseline chemistries 6/21/2013 Dr.T.V.Rao MD 45
  • 46. Imaging Chest x-ray – Look for multiple focal infiltrates and calcification of heart valves ECG – Rarely diagnostic – Look for evidence of ischemia, conduction delay, and arrhythmias Echocardiography 6/21/2013 Dr.T.V.Rao MD 46
  • 47. Indications for Echocardiography Transthoracic echocardiography (TTE) –First line if suspected IE –Native valves Trans esophageal echocardiography (TEE) –Prosthetic valves –Intracardiac complications –Inadequate TTE –Fungal or S. aureus or bacteremia 6/21/2013 Dr.T.V.Rao MD 47
  • 48. Making the Diagnosis Pelletier and Petersdorf criteria (1977) – Classification scheme of definite, probable, and possible IE – Reasonably specific but lacked sensitivity Von Reyn criteria (1981) – Added “rejected” as a category – Added more clinical criteria – Improved specificity and clinical utility Duke criteria (1994) – Included the role of echocardiography in diagnosis – Added IVDA as a “predisposing heart condition” 6/21/2013 Dr.T.V.Rao MD 48
  • 49. Modified Duke Criteria Definite IE – Microorganism (via culture or histology) in a valvular vegetation, embolized vegetation, or intracardiac abscess – Histologic evidence of vegetation or intracardiac abscess Possible IE – 2 major – 1 major and 3 minor – 5 minor Rejected IE – Resolution of illness with four days or less of antibiotics 6/21/2013 Dr.T.V.Rao MD 49
  • 50. Bacterial Endocarditis Therapy and Prophylaxis 1. Prolonged; high dosages; use of bactericidal drugs 2. Serum antibiotic levels and MBC of the organism 3. Viridans streptococci, Enterococcus, S. aureus, S. pneumoniae, S. pyogenes 4. Institution of therapy on empirical grounds 5. Proven negative blood cultures on Abx 6. Prophylaxis: dental extraction, GU. 6/21/2013 Dr.T.V.Rao MD 50
  • 51. Treatment Parenteral (IV) antibiotics –High serum concentrations to penetrate vegetation's –Prolonged treatment to kill dormant bacteria clustered in vegetation's Surgery –Intracardiac complications/paravalve abscess Surveillance blood cultures 6/21/2013 Dr.T.V.Rao MD 51
  • 52. Treatment - Specific Modify empiric therapy once cultures/sensitivities known Long duration 4-6 weeks Rx is required Refer to Trust Guidelines / BSAC Working Party Guidelines (2004) Liaise with Microbiologist Liaise with Cardiac Surgeon if needed Monitor response to treatment (clinical, CRP, ECHO) & look for complications 6/21/2013 Dr.T.V.Rao MD 52
  • 53. Complications Four etiologies –Embolic –Local spread of infection –Metastatic spread of infection –Formation of immune complexes – glomerulonephritis and arthritis 6/21/2013 Dr.T.V.Rao MD 53
  • 54. Embolic Complications Occur in up to 40% of patients with IE Predictors of embolization –Size of vegetation –Left-sided vegetation's –Fungal pathogens, S. aureus, and Strep. Bovis Incidence decreases significantly after initiation of effective antibiotics 6/21/2013 Dr.T.V.Rao MD 54
  • 55. Embolic Complications Stroke Myocardial Infarction – Fragments of valvular vegetation or vegetation- induced stenosis of coronary ostia Ischemic limbs Hypoxia from pulmonary emboli Abdominal pain (splenic or renal infarction) 6/21/2013 Dr.T.V.Rao MD 55
  • 56. Metastatic Spread of Infection Meningitis and/or encephalitis Vertebral osteomyelitis Metastatic abscess –Kidneys, spleen, brain, soft tissues Septic arthritis 6/21/2013 Dr.T.V.Rao MD 56
  • 57. Prevention – the procedure • Dental procedures known to produce bleeding • Tonsillectomy • Surgery involving GI, respiratory mucosa • Esophageal dilation • ERCP for obstruction • Gallbladder surgery • Cystoscopy, urethral dilation • Urethral catheter if infection present • Urinary tract surgery, including prostate • I&D of infected tissue 6/21/2013 Dr.T.V.Rao MD 57
  • 58. Antibiotic Therapy • Treatment tailored to etiologic agent –Important to note MIC/MBC relationship for each causative organism and the antibiotic used –High serum concentration necessary to penetrate avascular vegetation –ID CONSULT EVERY TIME 6/21/2013 Dr.T.V.Rao MD 58
  • 59. Antibiotic Therapy • Effective antimicrobial treatment should lead to defervescence within 7 – 10 days –Persistent fever in: • IE due to staph, pseudomonas, culture negative • IE with micro vascular complications/major emboli • Intracardiac/extra cardiac septic complications • Drug reaction 6/21/2013 Dr.T.V.Rao MD 59
  • 60. Prevention • Prophylactic regimen targeted against likely organism –Strep. viridans – oral, respiratory, esophageal –Enterococcus – genitourinary, gastrointestinal –S. aureus – infected skin, mucosal surfaces 6/21/2013 Dr.T.V.Rao MD 60
  • 61. Prevention – the underlying lesion • High risk lesions – Prosthetic valves – Prior IE – Cyanotic congenital heart disease – PDA – AR, AS, MR,MS with MR – VSD – Coarctation – Surgical systemic-pulmonary shunts • Intermediate risk – MVP with murmur – Pure MS – Tricuspid disease – Pulmonary stenosis – ASH – Bicuspid Ao valve with no hemodynamic significance Lesions at highest risk 6/21/2013 Dr.T.V.Rao MD 61
  • 62. Current Trends Uncommon bacteria a concern • Endocarditis has been documented for approximately 450 years, the diagnostic challenges and treatment dilemmas are as real today as they were in the time of Fernel . Major advances have been made in the diagnosis of endocarditis, in both laboratory and clinical (imaging) parameters, but we are witnessing the emergence of several newly described causal bacterial species, such as Tropheryma whippelii and Bartonella spp., as well as sporadic case reports of unusual and uncommon causal organisms, including Finegoldia sp., Gemella spp., and Abiotrophia defective. 6/21/2013 Dr.T.V.Rao MD 62
  • 63. Molecular Methods • In addition, since diagnostic methods, mainly 16S rDNA polymerase chain reaction (PCR) and sequencing, are now beginning to identify such infections, no evidence base exists to help determine effective antimicrobial drug regimens to successfully treat endocarditis caused by such organisms. Furthermore, as specimens from many of these infections are culture-negative, conventional antibiotic susceptibility testing does not help the cardiologist decide on the most suitable antimicrobial drug regimens. 6/21/2013 Dr.T.V.Rao MD 63
  • 64. New challenges in Endocarditis • 1) the emergence of antimicrobial resistance in classic infective endocarditis microflora, namely, the gram- positive cocci; 2) the existence of antimicrobial resistance in complex ecologic biofilms; 3) the changing pattern of causal agents now regarded as important pathogens of infective endocarditis, e.g., Bartonella spp., T. whippelii, and fungi; and 4) changing epidemiologic trends of persons who acquire infective endocarditis, including injection drug users, persons with HIV/AIDS, children with congenital heart defects, and persons undergoing body piercing. 6/21/2013 Dr.T.V.Rao MD 64
  • 65. References • Emerging Issues in Infective Endocarditis Beverley C. Millar* and John E. Moore • Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy F. Kate Gould etal 6/21/2013 Dr.T.V.Rao MD 65
  • 66. • The Programme created by Dr.T.V.Rao MD for Medical Professionals in the Developing World • Email • doctortvrao@gmail.com 6/21/2013 Dr.T.V.Rao MD 66